Osteoarthritis: What It Is, Why It Progresses, and How Regenerative Medicine Is Changing Treatment
Osteoarthritis at a Glance
- Affects over 500 million people worldwide, making it the most common form of arthritis.
- Not just “wear and tear.” OA involves active inflammation, cartilage breakdown, and changes to the entire joint.
- Conventional treatments focus on symptom management (painkillers, cortisone, joint replacement).
- Regenerative medicine aims to slow or reverse damage by supporting the body’s own repair processes.
- Most patients are good candidates for at least one regenerative approach, depending on disease stage and joint involved.
What Osteoarthritis Actually Is (It Is Not Just Wear and Tear)
For decades, doctors described osteoarthritis as a “wear and tear” disease. That framing is outdated, incomplete, and frankly misleading. Yes, mechanical stress plays a role. But OA is a whole-joint disease with active biological processes driving its progression.
Here is what actually happens inside an osteoarthritic joint:
Cartilage degradation: Articular cartilage, the smooth tissue covering bone ends, breaks down. Specialized enzymes called matrix metalloproteinases (MMPs) actively dissolve the collagen and proteoglycan matrix. This is not passive erosion. It is enzymatic destruction triggered by inflammatory signals.
Chronic low-grade inflammation: The synovial membrane (joint lining) becomes inflamed. Inflammatory cytokines like IL-1beta, TNF-alpha, and IL-6 flood the joint, accelerating cartilage loss and causing pain. This is why researchers now sometimes call OA a “low-grade inflammatory arthropathy.”
Subchondral bone changes: The bone beneath the cartilage thickens and develops lesions (bone marrow lesions). Osteophytes, commonly called bone spurs, form around the joint margins as the body tries to stabilize the deteriorating structure.
Synovial fluid breakdown: Healthy joints rely on synovial fluid rich in hyaluronic acid for lubrication and nutrient delivery. In OA, this fluid becomes thinner and less effective, starving cartilage of the nutrients it needs to maintain itself.
Muscle and ligament involvement: Surrounding muscles weaken, ligaments become lax, and the entire biomechanical unit shifts. This feeds a cycle of abnormal loading, further joint damage, and increasing pain.
Understanding OA as a multi-tissue, actively inflammatory disease matters because it changes how we think about treatment. If the disease were purely mechanical, replacement would be the only logical endpoint. But because active biological processes drive OA, biological treatments can potentially intervene in those processes.
Stages of Osteoarthritis: The Kellgren-Lawrence Grading System
Doctors typically stage OA severity using the Kellgren-Lawrence (KL) grading system, based on X-ray findings. Knowing your grade helps determine which treatments make the most sense.
| KL Grade | X-Ray Findings | What It Means | Treatment Options |
|---|---|---|---|
| Grade 0 | Normal joint | No OA present | Prevention, exercise, weight management |
| Grade 1 | Doubtful narrowing, possible osteophytes | Very early changes, often no symptoms | Lifestyle, PRP, prolotherapy |
| Grade 2 | Definite osteophytes, possible narrowing | Mild OA, occasional pain and stiffness | PRP, prolotherapy, stem cells, shockwave |
| Grade 3 | Multiple osteophytes, definite narrowing, some sclerosis | Moderate OA, frequent pain, reduced function | Stem cells, PRP, exosomes, shockwave |
| Grade 4 | Large osteophytes, severe narrowing, bone-on-bone | Severe OA, constant pain, significant disability | Stem cells, exosomes (or joint replacement if unresponsive) |
Important note: X-ray grade does not always match symptom severity. Some patients with Grade 4 X-rays have manageable pain, while others with Grade 2 imaging are miserable. MRI provides much better detail about soft tissue, cartilage thickness, bone marrow lesions, and meniscal status. A good regenerative medicine evaluation should include MRI, not just X-rays.
Conventional Treatment vs. Regenerative Medicine: Two Different Philosophies
The standard medical approach to OA follows a predictable ladder: over-the-counter painkillers, prescription anti-inflammatories, physical therapy, cortisone injections, hyaluronic acid injections, and eventually joint replacement surgery. Each step manages symptoms while the disease continues to progress.
Regenerative medicine takes a fundamentally different approach. Rather than masking pain while cartilage continues to deteriorate, regenerative treatments aim to:
- Reduce the chronic inflammation driving cartilage loss
- Supply growth factors and signaling molecules that support tissue repair
- Recruit and activate the body’s own stem cells
- Improve the joint’s internal environment so healing becomes possible
This does not mean that regenerative medicine is right for every patient, or that conventional treatments have no value. Physical therapy, in particular, is essential regardless of which path you choose. But the philosophy is different: treat the disease process, not just the symptoms.
A word on cortisone: While cortisone injections provide short-term pain relief, research published in Radiology (2019) found that repeated cortisone injections were associated with accelerated cartilage loss and increased risk of needing joint replacement. A single cortisone injection for acute flares may be reasonable, but routine repeated injections deserve caution.
Regenerative Treatments for Osteoarthritis
1. Stem Cell Therapy (Mesenchymal Stem/Stromal Cells)
Stem cell therapy for OA typically uses mesenchymal stem cells (MSCs) harvested from the patient’s own bone marrow or adipose (fat) tissue. These cells are concentrated and injected directly into the affected joint under ultrasound or fluoroscopic guidance.
MSCs work through several mechanisms. They release anti-inflammatory cytokines that calm the destructive immune response in the joint. They secrete growth factors (like TGF-beta, IGF-1, and VEGF) that stimulate cartilage cell activity. And there is evidence they can differentiate into cartilage-like cells, though the paracrine (signaling) effects appear to be more important than direct cell replacement.
Best candidates: KL Grade 2-4, especially patients who want to delay or avoid joint replacement. Results tend to be strongest in Grade 2-3 patients, though meaningful improvement is possible even in Grade 4.
2. Platelet-Rich Plasma (PRP)
PRP therapy concentrates the growth factors and anti-inflammatory proteins from your own blood. A small blood draw is processed in a centrifuge to isolate a platelet-rich fraction, which is then injected into the joint.
PRP works primarily by delivering concentrated growth factors (PDGF, TGF-beta, VEGF, EGF) and anti-inflammatory mediators directly to the damaged tissue. It reduces synovial inflammation, supports cartilage cell metabolism, and can improve the quality of synovial fluid.
Best candidates: KL Grade 1-3, athletes and active individuals with early-to-moderate OA, patients looking for a less invasive starting point.
3. Prolotherapy
Prolotherapy involves injecting a dextrose (sugar water) solution into and around the joint. This creates a mild, controlled inflammatory response that triggers the body’s healing cascade. Think of it as pressing the “reset” button on a stalled repair process.
While prolotherapy is the simplest and most affordable regenerative injection, it should not be underestimated. A 2017 systematic review in the Journal of Alternative and Complementary Medicine found that dextrose prolotherapy produced clinically meaningful improvements in pain, function, and stiffness for knee OA.
Best candidates: KL Grade 1-2, patients with joint laxity or instability contributing to OA, budget-conscious patients who want a proven starting treatment.
4. Exosome Therapy
Exosome therapy uses extracellular vesicles (tiny cell-derived packets of growth factors, proteins, and RNA) derived from mesenchymal stem cells. Exosomes carry much of the regenerative signaling power of stem cells without the cells themselves.
Early research suggests exosomes may reduce cartilage degeneration, suppress inflammatory pathways, and promote tissue repair. They can be combined with PRP or stem cell injections for a synergistic effect. This is a newer therapy with less long-term clinical data than PRP or stem cells, but the preclinical evidence is promising.
Best candidates: KL Grade 2-4, patients who may not have sufficient stem cell quality due to age or health conditions, often used as an adjunct to other regenerative treatments.
5. Extracorporeal Shockwave Therapy (ESWT)
Shockwave therapy delivers focused acoustic waves to the affected area. These pulses stimulate blood flow, trigger growth factor release, and reduce substance P (a pain signaling molecule). It is non-invasive, requires no injections, and is typically done in a series of sessions.
Shockwave therapy works particularly well for OA-related pain and stiffness, especially when combined with injection-based therapies. It also helps with periarticular soft tissue problems (like tendinopathy) that often accompany OA.
Best candidates: KL Grade 1-3, patients who prefer non-injection treatments, excellent as a complement to PRP or stem cell therapy.
Evidence Summary: Regenerative Treatments for OA
The evidence base for regenerative OA treatments has grown significantly in recent years. Here is a summary of the current state of research for each modality.
| Treatment | Level of Evidence | Key Findings | Limitations |
|---|---|---|---|
| PRP | Strong (multiple RCTs, meta-analyses) | Consistently outperforms hyaluronic acid and cortisone for knee OA pain and function at 6-12 months. 2021 meta-analysis in AJSM: significant improvement in WOMAC scores. | Preparation protocols vary widely between clinics, making comparisons difficult. Leukocyte-poor PRP may be preferable for intra-articular use. |
| Stem Cells (MSCs) | Moderate-to-strong (RCTs, prospective studies) | Multiple studies show pain reduction, improved function, and in some cases MRI evidence of cartilage regeneration. 2020 systematic review: 78% of patients showed clinical improvement at 12+ months. | Cell source, processing, and dosing are not yet standardized. Long-term data (5+ years) is still limited. |
| Prolotherapy | Moderate (RCTs, systematic reviews) | Saline-controlled trials show significant pain and function improvements for knee OA. Effects may be durable at 1-2 years. | Mechanism of action not fully characterized. Often requires multiple treatment sessions. |
| Exosomes | Early (preclinical, case series) | Animal studies show reduced cartilage degradation and inflammation. Human case series report pain improvement, but large controlled trials are not yet available. | Regulatory landscape is evolving. Source and quality of exosome products vary significantly. |
| Shockwave (ESWT) | Moderate (RCTs) | Systematic reviews show ESWT reduces OA pain and improves function, especially in knee OA. Benefits often sustained at 6-12 months. | Optimal parameters (energy level, number of sessions) not fully established. Less studied for advanced OA. |
Lifestyle, Exercise, and Supplement Approaches
Regenerative injections work best when paired with the right lifestyle foundation. These strategies support joint health and can improve treatment outcomes.
Exercise: The Single Most Important Thing You Can Do
Controlled, progressive exercise is the most evidence-supported intervention for OA, period. It reduces pain, improves function, slows progression, and enhances the results of regenerative treatments.
- Strength training: Strengthening the muscles around a joint reduces load on damaged cartilage and improves stability. Quadriceps strengthening is especially critical for knee OA.
- Low-impact aerobic exercise: Walking, cycling, swimming, and elliptical training improve circulation, reduce inflammation, and support weight management without excessive joint stress.
- Flexibility and mobility work: Gentle stretching, yoga, and range-of-motion exercises prevent stiffness and maintain joint function.
- Balance training: Particularly important for hip and knee OA to prevent falls and improve proprioception.
Weight Management
Every pound of body weight translates to roughly 3 to 5 pounds of force across the knee during walking. Losing even 10 pounds can reduce knee joint loading by 30 to 50 pounds per step. Weight loss also reduces systemic inflammation, which directly impacts OA progression.
Supplements with Evidence
Glucosamine and Chondroitin: The evidence is mixed but generally positive for glucosamine sulfate (not hydrochloride) at 1500mg daily. A 2018 Cochrane review found modest improvements in pain and function. Chondroitin sulfate at 800-1200mg daily has similar modest evidence. These work best for mild-to-moderate OA and may take 8-12 weeks to show benefit.
Collagen peptides: Type II collagen (UC-II, 40mg daily) and hydrolyzed collagen (10g daily) have shown promise in clinical trials. A 2022 meta-analysis found collagen supplementation significantly improved OA pain scores compared to placebo.
Omega-3 fatty acids: EPA and DHA (combined 2-3g daily) reduce inflammatory markers associated with OA progression. The anti-inflammatory effects complement regenerative treatments well.
Vitamin D: Deficiency is common in OA patients and associated with faster cartilage loss. Maintaining serum levels of 40-60 ng/mL is recommended. Supplementation of 2000-5000 IU daily is typical depending on baseline levels.
Curcumin: Bioavailable formulations (look for those with piperine or liposomal delivery) at 500-1000mg daily have shown anti-inflammatory effects comparable to ibuprofen in some trials, without the GI side effects.
Cost Comparison: Conventional vs. Regenerative Treatments
Cost is a real consideration. Most regenerative treatments are not covered by insurance, and transparency about pricing matters. Here is how the costs compare.
| Treatment | Typical Cost Range | Sessions Needed | Insurance Coverage |
|---|---|---|---|
| Over-the-counter NSAIDs | $10-30/month | Ongoing | N/A |
| Physical therapy | $50-150/session (copay varies) | 8-12+ sessions | Usually covered |
| Cortisone injection | $100-350 | Up to 3-4/year | Usually covered |
| Hyaluronic acid injection (Synvisc, etc.) | $500-2,000 per series | 1-3 injections per series | Sometimes covered |
| Prolotherapy | $300-700/session | 3-6 sessions | Rarely covered |
| PRP therapy | $500-1,500/injection | 1-3 injections | Rarely covered |
| Shockwave therapy (ESWT) | $300-500/session | 3-6 sessions | Rarely covered |
| Stem cell therapy | $3,000-8,000 per joint | Usually 1 (may repeat at 1-2 years) | Not covered |
| Exosome therapy | $3,000-7,000 per joint | Usually 1-2 | Not covered |
| Total knee replacement surgery | $30,000-70,000+ | 1 (with 3-6 month recovery) | Usually covered |
The real cost calculation: When comparing regenerative treatments to joint replacement, factor in total cost. A knee replacement involves surgery, anesthesia, hospital stay, implant costs, physical therapy (months of it), time off work (typically 6-12 weeks), and the risk of complications. Many patients who invest $5,000-$10,000 in regenerative care find it far more cost-effective than the full burden of joint replacement, especially when it buys years of pain-free function.
Frequently Asked Questions
Can osteoarthritis be reversed?
Completely reversing advanced OA is not realistic with current technology. However, regenerative treatments can slow progression, reduce pain significantly, improve function, and in some cases produce measurable cartilage regeneration on MRI. The earlier treatment begins, the better the outcomes tend to be. Think of it as shifting the trajectory of the disease rather than fully reversing it.
How do I know if I am a candidate for regenerative treatment?
Most people with OA are candidates for at least one regenerative approach. The best way to find out is through a consultation that includes a physical exam, imaging review (ideally MRI), and a discussion of your goals. Factors that influence the recommendation include your KL grade, which joint is affected, your activity level, overall health, and prior treatments.
Is PRP or stem cell therapy painful?
The injection itself causes temporary discomfort similar to any joint injection. Most clinics use local anesthetic and image guidance to minimize pain. For stem cell therapy, the bone marrow aspiration is the most uncomfortable part, but it is brief (usually 10-15 minutes) and manageable with local anesthesia. Most patients describe the discomfort as a 3-4 out of 10. Expect some soreness and swelling in the joint for 3-7 days after injection, which is part of the healing response.
How long do regenerative treatments last?
Results vary by treatment and individual. PRP typically provides 9-18 months of benefit and can be repeated. Stem cell therapy often provides 2-5 years of improvement, with some patients maintaining benefits longer. Prolotherapy results tend to be durable once the full treatment series is complete. Many patients benefit from periodic “booster” treatments to maintain results over the long term.
Can I still get a joint replacement later if regenerative treatment does not work?
Absolutely. Regenerative treatments do not burn any bridges. Unlike cortisone (which may accelerate cartilage loss) or arthroscopic surgery (which removes tissue), regenerative injections do not damage the joint or complicate future surgery. If regenerative treatment does not provide adequate relief, joint replacement remains a viable option. Many patients use regenerative medicine to delay replacement by years, getting surgery only if and when it becomes truly necessary.
What should I look for in a regenerative medicine clinic?
Look for physicians with specific training in regenerative medicine (not just a weekend course). Injections should be performed under image guidance (ultrasound or fluoroscopy), not blindly. Ask about the preparation protocols they use for PRP and stem cells, because quality varies enormously. The clinic should perform a thorough evaluation (including imaging review) before recommending treatment, and they should be transparent about expected outcomes, costs, and limitations.
Are regenerative treatments FDA-approved?
PRP and bone marrow aspirate concentrate (BMAC) use the patient’s own cells and blood products with minimal processing, which falls under the FDA’s “same surgical procedure” exception. They do not require specific FDA approval. Exosome products exist in a more complex regulatory space, and patients should ask their provider about the source and regulatory status of any exosome product. No regenerative injection therapy has received formal FDA approval specifically for OA treatment, though the individual components are legal to use in medical practice.
Related Guides
- Stem Cell Therapy: A Complete Guide
- PRP Therapy: How It Works, What to Expect, and Who Benefits
- Prolotherapy: The Evidence-Based Injection You Have Not Heard Of
- Exosome Therapy: The Next Frontier in Regenerative Medicine
- Shockwave Therapy: How Acoustic Waves Promote Healing
References
- Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019;393(10182):1745-1759.
- Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16(4):494-502.
- McAlindon TE, et al. Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial. JAMA. 2017;317(19):1967-1975.
- Zhu Y, et al. Comparison of platelet-rich plasma vs hyaluronic acid for knee osteoarthritis: a systematic review and meta-analysis. Am J Sports Med. 2021;49(7):1951-1960.
- Kim SH, et al. Mesenchymal stem cell implantation for osteoarthritis: a systematic review and meta-analysis. Arch Orthop Trauma Surg. 2019;139(7):971-980.
- Sit RWS, et al. Efficacy of dextrose prolotherapy for knee osteoarthritis: a systematic review. J Altern Complement Med. 2017;23(10):751-757.
- Zhi Z, et al. Effect of extracorporeal shock wave therapy on osteoarthritis: a systematic review and meta-analysis. J Rehabil Med. 2022;54:jrm00278.
- Liu X, et al. Exosomes derived from mesenchymal stem cells for treatment of osteoarthritis: a review of preclinical evidence. Front Bioeng Biotechnol. 2021;9:666212.
- Zeng C, et al. Effectiveness and safety of glucosamine, chondroitin, and the two in combination for knee osteoarthritis: a systematic review and meta-analysis. Cochrane Database Syst Rev. 2018.
- Garcia-Coronado JM, et al. Effect of collagen supplementation on osteoarthritis symptoms: a meta-analysis of randomized placebo-controlled trials. Int Orthop. 2019;43(3):531-538.
- Messier SP, et al. Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis. JAMA. 2013;310(12):1263-1273.
- Kompel AJ, et al. Intra-articular corticosteroid injections and long-term structural progression in knee osteoarthritis. Radiology. 2019;293(3):656-663.
